ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
US Tech 100
20,836.00
1.31%
Dow Jones
42,840.26
1.18%
Brent Oil
72.72
0.00%
Bitcoin
97,651.99
-0.11%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Emergent Biosolutions Inc (EBS) Quote

Emergent Biosolutions Inc

Emergent Biosolutions Inc (EBS)

NYSE
8.10
0.04
(0.50%)
Closed December 21 4:00PM
Delayed by 15 minutes
8.07
-0.03
(-0.37%)
After Hours: 7:46PM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
8.07
Bid
-
Ask
-
Volume
2,499,434
7.70 Day's Range 8.35
1.42 52 Week Range 15.10
Market Cap
437.266M
Previous Close
8.06
Open
7.85
Last Trade
25
@
8.12
Last Trade Time
Financial Volume
$ 20,285,722
VWAP
8.1161
Average Volume (3m)
1,375,955
Shares Outstanding
54,184,186
Dividend Yield
-
PE Ratio
-0.58
Earnings Per Share (EPS)
-14.04
Revenue
1.05B
Net Profit
-760.5M

About Emergent Biosolutions Inc

Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based... Emergent BioSolutions offers public health products to government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccine, device, and therapeutic products. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.emergentbiosolutions.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Emergent Biosolutions Inc is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker EBS. The last closing price for Emergent Biosolutions was $8.06. Over the last year, Emergent Biosolutions shares have traded in a share price range of $ 1.42 to $ 15.10.

Emergent Biosolutions currently has 54,184,186 shares outstanding. The market capitalization of Emergent Biosolutions is $436.72 million. Emergent Biosolutions has a price to earnings ratio (PE ratio) of -0.58.

Ask ADVFN Intelligence (AI)

Emergent Biosolutions (EBS) Options Flow Summary

EBS Options Flow

Overall Flow

Bullish

Net Premium

26k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

EBS Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

December 17 2024
Edgar (US Regulatory)

Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)

GAITHERSBURG, Md., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the Biomedical Advanced Research and Development Authority (BARDA) within the...

December 16 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

December 10 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

December 05 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

December 04 2024
Edgar (US Regulatory)

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

December 02 2024
Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities

November 21 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 14 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 13 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

November 13 2024
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.74-8.399545970498.819.038.0111133168.47271327CS
4-1.33-14.14893617029.410.438.019180699.06696076CS
120.7410.09549795367.3312.737.0313759559.25081268CS
261.8429.53451043346.2315.15.2522752029.16052518CS
525.62229.3877551022.4515.11.4230597845.50249703CS
156-36.64-81.950346678644.7152.771.4218253179.1459139CS
260-45.83-85.027829313553.9137.611.42136320122.24219125CS

EBS - Frequently Asked Questions (FAQ)

What is the current Emergent Biosolutions share price?
The current share price of Emergent Biosolutions is $ 8.07
How many Emergent Biosolutions shares are in issue?
Emergent Biosolutions has 54,184,186 shares in issue
What is the market cap of Emergent Biosolutions?
The market capitalisation of Emergent Biosolutions is USD 436.72M
What is the 1 year trading range for Emergent Biosolutions share price?
Emergent Biosolutions has traded in the range of $ 1.42 to $ 15.10 during the past year
What is the PE ratio of Emergent Biosolutions?
The price to earnings ratio of Emergent Biosolutions is -0.58
What is the cash to sales ratio of Emergent Biosolutions?
The cash to sales ratio of Emergent Biosolutions is 0.42
What is the reporting currency for Emergent Biosolutions?
Emergent Biosolutions reports financial results in USD
What is the latest annual turnover for Emergent Biosolutions?
The latest annual turnover of Emergent Biosolutions is USD 1.05B
What is the latest annual profit for Emergent Biosolutions?
The latest annual profit of Emergent Biosolutions is USD -760.5M
What is the registered address of Emergent Biosolutions?
The registered address for Emergent Biosolutions is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Emergent Biosolutions website address?
The website address for Emergent Biosolutions is www.emergentbiosolutions.com
Which industry sector does Emergent Biosolutions operate in?
Emergent Biosolutions operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VNCEVince Holding Corp
$ 4.70
(69.06%)
1.06M
SRFMSurf Air Mobility Inc
$ 3.33
(23.79%)
376.77k
BBBlackBerry Limited
$ 3.685
(23.66%)
40.8M
ALURAllurion Technologies Inc
$ 0.3439
(22.87%)
744.34k
CLWClearWater Paper Corporation
$ 30.26
(22.46%)
3.5M
IIPRInnovative Industrial Properties Inc
$ 73.50
(-22.91%)
3.15M
KUKEKuke Music Holding Limited
$ 0.31
(-20.51%)
61.48k
NVONovo Nordisk
$ 85.00
(-17.83%)
53.81M
CANGCango Inc
$ 5.08
(-11.81%)
2.44M
BNEDBarnes and Noble Education Inc
$ 9.965
(-10.31%)
1.55M
QBTSD Wave Quantum Inc
$ 6.638
(4.21%)
124.42M
PFEPfizer Inc
$ 26.36
(2.29%)
116.33M
APOApollo Global Management Inc
$ 171.03
(0.83%)
94.52M
TAT&T Inc
$ 22.75
(0.80%)
93.94M
FFord Motor Company
$ 9.885
(1.49%)
87.66M

EBS Discussion

View Posts
PonkenPlonken PonkenPlonken 1 week ago
https://www.cnbc.com/2024/12/13/mckinsey-co-to-pay-650-million-to-settle-us-opioid-consulting-probe-ex-partner-will-plead-guilty-to-obstruction.html
👍️0
EarningsCentral EarningsCentral 1 month ago
👍️0
tw0122 tw0122 1 month ago
NARCAN rules bring them back from the dead $11.31 + 22%
👍️0
eyeownu eyeownu 3 months ago
easy money
👍️0
eyeownu eyeownu 3 months ago
$EBS bonds already higher than a few weeks ago (share price here was at 15$), but shorty morons still believe that we should be lower.

The lesson will be painful. https://stocktwits.com/WinstonSmith33/message/587766900
👍️0
eyeownu eyeownu 3 months ago
$EBS Emergent BioSolutions Announces Closing of $100 Million Asset-Backed Loan Facility https://markets.businessinsider.com/news/stocks/emergent-biosolutions-announces-closing-of-100-million-asset-backed-loan-facility-1033814631
👍️0
Stockexpertpro Stockexpertpro 3 months ago
EBS California to Require narcan be at all businesses in the state singed into law mins ago This could go nationwide
👍️0
eyeownu eyeownu 3 months ago
$EBS Newsom signs bill pushing for Narcan in workplace first aid kits https://www.latimes.com/california/story/2024-09-28/california-naloxone-first-aid-kits
👍️0
eyeownu eyeownu 3 months ago
$EBS amazon to stock narcan at workplace https://www.wsj.com/business/amazon-to-stock-opioid-overdose-reversal-drug-narcan-at-its-warehouses-2ea8d831
👍️0
eyeownu eyeownu 3 months ago
$EBS https://newstalkkgvo.com/montana-narcan-kits-public/ Missoula, MT (KGVO-AM News) - Montana Attorney General Austin Knudsen appeared on Monday’s Talk Back show to continue his emphasis on the fight against fentanyl coming into Montana. Knudsen began by reminding listeners about just how deadly fentanyl can be.

“Narcan is a counter agent to fentanyl,” began Knudsen. “Fentanyl is a synthetic opioid. That opioid molecule, once you ingest it, attaches to your brain stem and it puts you into a deep, deep sleep by knocking you out. For a lot of people, it makes you stop breathing and you die.”



Read More: Montana AG Wants Narcan First Aid Kits in Public Spaces | https://newstalkkgvo.com/montana-narcan-kits-public/?utm_source=tsmclip&utm_medium=referral
👍️0
eyeownu eyeownu 3 months ago
my $EBS bags are heavy
👍️0
Biggiee Biggiee 3 months ago
Looks like when EBS refinanced their debt, they became the usual “sell the news” kind of stock. Too bad, it had a good honest run from $2-$15. Biz as usual now
👍️0
Roadtojourney Roadtojourney 3 months ago
What a waste, liars $400 million order to sell the shares seems like???
👍️0
Monksdream Monksdream 3 months ago
EBS chart
👍️0
eyeownu eyeownu 4 months ago
added more this will be in double digits in no time. alllllllllllll aboard.
👍️0
allenc allenc 4 months ago
Expect we see a contract for the vaccine soon. $200M in debt reduction, anticipating increase sales of Narcan, this should be a booming Q4 IMO.
👍️ 1
Biggiee Biggiee 4 months ago
https://www.unicef.org/press-releases/unicef-issues-emergency-tender-secure-mpox-vaccines-crisis-hit-countries
👍️0
eyeownu eyeownu 4 months ago
bought 2500 shares today
👍️0
Biggiee Biggiee 4 months ago
Nasty bull trap with that FDA news ah yesterday, but should snap back to double digits when the dark overlords are done playing
👍️0
81vette 81vette 4 months ago
Tutes own 58%,short 3.5m(covering coming)shares to short dropping now,fee rising and rebate dropping,tutes want their shares back before it runs up,patience required on my part isn’t easy lol.
👍️0
Biggiee Biggiee 4 months ago
Loading up now, see you next week!
GLTA
👍️0
Roadtojourney Roadtojourney 4 months ago
What a pos seems like approval was already priced in?? Sell on news??
👍️0
Biggiee Biggiee 4 months ago
FDA approval for MPOX
👍️0
Biggiee Biggiee 4 months ago
$EBS Rodman & Renshaw initiated coverage of Emergent Biosolutions (NYSE: EBS) with a price target of $16.
👍️0
LEFTY1182 LEFTY1182 4 months ago
Soon enough people will catch on with the monkey pox coming! $200+ coming here imo
👍️0
Biggiee Biggiee 4 months ago
Why do I bother messaging this board? Talking to myself! Goodnight!
👍️0
Biggiee Biggiee 4 months ago
It’s go time once more!
👍️0
Biggiee Biggiee 4 months ago
Selling my 9’s here @10.10. Quick flip, I think she goes lower.
GLTA
👍️0
Biggiee Biggiee 4 months ago
Sold yesterday, looking for a pullback now to $9’s. Media hasn’t latched on to the crisis fear just yet, we shall see
$EBS
👍️0
81vette 81vette 4 months ago
Shares to short dropping,getting excited as word is spreading faster than the virus lol
👍️0
81vette 81vette 4 months ago
3.6m short,could squeeze big after hrs
👍️0
Biggiee Biggiee 4 months ago
The coming news cycle of “fear the mpox” will do more than just pop. I see a sustained rising trend from here on out. Start looking at the weekly and monthly charts instead of the daily.
$EBS
👍️0
EnchantedTitan62 EnchantedTitan62 4 months ago
If they get FDA approval which they are now seeking, it will surely pop again.
👍️0
Biggiee Biggiee 4 months ago
It’s go time again, monkey biz
👍️0
Biggiee Biggiee 4 months ago
Yikes! Smoldering crater
👍️0
Biggiee Biggiee 4 months ago
Todays the day! Place your bets for AH
GLtA
👍️0
Biggiee Biggiee 5 months ago
Tree shake! Earnings coming on Aug 6 AH
One to watch $EBS
👍️0
Biggiee Biggiee 5 months ago
Feels like it could be a buy out. Market cap isn’t even a billy, and we are talking about NARCAN! Any guesses above these prices seems like a good bet
👍️0
Sirpeter Sirpeter 5 months ago
How high do you see this going
👍️0
Biggiee Biggiee 5 months ago
F’in beast! $14!
👍️0
Biggiee Biggiee 5 months ago
$13 hit. Such a beast!
👍️0
Biggiee Biggiee 5 months ago
Jumped back in $12.01, I think it’s time to challenge $13
👍️0
Biggiee Biggiee 5 months ago
Looking for the right time to get back in here. $EBS
👍️0
EnchantedTitan62 EnchantedTitan62 5 months ago
Thanks, left some on the table too. I see youve been here for awhile so I'm ' following' ya for any good plays. My picks tend to be long term . Good day sir.
👍️0
Biggiee Biggiee 5 months ago
Nice! Cheers!
👍️0
EnchantedTitan62 EnchantedTitan62 5 months ago
Sold 175 @ 12.05 for $7 gain/share. Not enough to buy a beach house in Cape Cod, but I can buy a plane ticket ! Ha.
👍️0
Biggiee Biggiee 5 months ago
Out 12.20, will jump back in once they finish shaking the tree. Thanks!
👍️0
Biggiee Biggiee 5 months ago
lol, life goes on
👍️0
TrendTrade2016 TrendTrade2016 5 months ago
EBS...TOP IS IN
👍️0
EnchantedTitan62 EnchantedTitan62 5 months ago
Taking a break from chopping wood for the winter. Looks like another day IN THE GREEN. 💲
👍️0

Your Recent History

NYSE
EBS
Emergent Biosolutions
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads